(NaturalNews) AstraZeneca is investing $50 billion in U.S. operations by 2030, including its largest-ever manufacturing plant in Virginia specializing in respir…
AstraZeneca’s $50B U.S. expansion signals shift in pharma manufacturing amid tariff threat

Estimated read time
1 min read
You May Also Like
More From Author
Who’s running to replace Mark Green in the House?
July 25, 2025
Jon Stewart MOCKS the black church
July 25, 2025